[Chosun Biz][Law Firm Practice Skills] Lee & Ko Protects Boryung Pharmaceutical’s Right in Hypertension Treatment with KRW 50 Billion in Sales
On January 8, 2024, Chosun Biz reported Lee & Ko’s recent win for Boryung Pharmaceutical, noting that “as the efficacy of Dukarb®, Boryung’s hypertension drug, went viral, it became the target of other Korean pharmaceutical companies” but “Boryung has defended its Dukarb® patent all the way from the Intellectual Property Trial and Appeal Board stage to the ensuing trials, with Lee & Ko’s Healthcare Practice Group, led by Ms. Keum Nang Park, playing a key role in the defense.” Ms. Park remarked in an interview that “this is the first time a Korean pharmaceutical company that has developed an original drug defended its patent rights in a large-scale dispute against multiple generic companies,” further noting that “we felt that this drug should be afforded patent protection especially since it was a new drug developed after many challenges in Korea, where new drug R&D is still rare.”
2024.01.08
[Hankyung] Lee & Ko Prevails in All 10 Lawsuits Relating to Boryung Pharmaceutical’s Ducarb® Patent
On December 5, 2023, Hankyung reported Lee & Ko’s recent win in the lawsuits involving Boryung Pharmaceutical’s combination drug patent related to Ducarb®, Boryung’s blockbuster drug. Representing the patentee, Lee & Ko won in all 10 cases, which included patent invalidation actions and negative scope confirmation actions. Lee & Ko’s team, with attorneys Keum Nang Park, Heon Lee and Eunkyoung Lyu and patent attorneys Tae Min Kim and Sungmin Cho, strategically crafted arguments based on sound and in-depth analysis of legal theories, ultimately securing this victory.
2023.12.05
[NEWS1] The Korean Intellectual Property Office and the National Assembly Discuss the Introduction of “K-Discovery” for Technology Protection
On September 13, 2023, News1 published an article on Lee & Ko attorney Hwan Sung Park’s panel participation in an upcoming debate to be held by the National Assembly. At the “National Assembly Debate Forum on Introducing K-Discovery for Patent Infringement Litigation,” to be held by the National Assembly and Korean Intellectual Property Office on September 14, Mr. Park, drawing on his years of hands-on experience, will present his opinions on issues relating to the proposed discovery system, including ways for minimizing leak of trade secret information in the course of factual investigation of experts and for excluding legal opinions from the scope of such expert investigation.
2023.09.13
[Korea Economic Daily] Law Firms Organizing 'Coin-related Crime TF' in Response to the Prosecution’s Virtual Assets Crime Joint Investigation Team
On July 23, 2023, Lee & Ko’s Virtual Assets Investigation Response Team, led by Mr. Kwang Bae Park, was featured in the Korea Economic Daily. The Korea Economic Daily reported that “Lee & Ko plans to incorporate the Virtual Assets Investigation Response TF into the official structure as the Virtual Assets Investigation Response Team, as early as the end of this month,” and “assign leading lawyers in the field of virtual assets from the existing criminal and digital finance teams.”
2023.07.23